SAT0006 T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3 (TIM-3) IS INCREASED IN ACTIVE RHEUMATOID ARTHRITIS AND ASSOCIATED WITH CLINICAL DISEASE ACTIVITY AND RADIOGRAPHIC PROGRESSION
Cæcilie Skejø(Aarhus University), Bent Deleuran(Aarhus University), Morten Aagaard Nielsen(Aarhus University Hospital), Mette Deleuran(Aarhus University Hospital), Peter Junker(Odense University Hospital), Kristian Stengaard‐Pedersen(Aarhus University Hospital), Malene Hvid(Aarhus University), Kim Hørslev‐Petersen(University of Southern Denmark), Merete Lund Hetland(University of Copenhagen), Mikkel Østergaard(University of Copenhagen), Stinne Ravn Greisen(Aarhus University), Aida S. Hansen(Aarhus University)
Cited by 2
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
|Arthritis Research & Therapy|2008|472
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419